Melatonin as a Modulator of Osseointegration: Mechanisms, Evidence and Clinical Potential in Implant Dentistry

Osseointegration, the biological integration of dental implants with bone, is critical for the long-term success of implant-supported restorations. Despite advances in implant materials and techniques, achieving rapid and reliable bone healing remains a challenge. Melatonin, a biologically active molecule with antioxidant, anti-inflammatory and immunomodulatory properties, has shown potential to enhance bone regeneration and implant stability. This study aims to evaluate the role of melatonin in promoting osseointegration and to explore its potential clinical applications in implant dentistry. A narrative review of laboratory, animal and preliminary clinical studies investigating the effects of melatonin on bone healing and implant stability was conducted. Studies were selected based on the use of melatonin in local application, systemic supplementation or incorporation into implant surfaces. Key outcomes assessed included osteoblast activity, osteoclast inhibition, vascularization, bone density and healing time. Laboratory and animal studies demonstrated that melatonin enhances osteoblast proliferation, reduces osteoclast-mediated bone resorption and promotes vascularization through the regulation of vascular endothelial growth factor. Preliminary clinical studies indicated improved bone density on radiographic assessment and reduced healing time following local melatonin application. However, evidence remains limited and heterogeneity in dosing, administration methods and follow-up periods was observed. Melatonin shows promising potential to enhance osseointegration and accelerate bone healing in dental implant procedures. While initial findings are encouraging, optimal dosing, delivery methods and long-term safety remain unclear. Well-designed, controlled clinical trials are necessary before melatonin can be recommended as a standard adjunct in implant dentistry.